Biotech VC
shizune.coBoehringer Ingelheim Venture Fund intends to invest in groundbreaking therapeutic approaches and technologies. Show more ... Nuevocor — Nuevocor is a preclinical-stage biopharmaceutical company focused on developing gene therapy‑based treatments that have the potential to restore cardiac function in diseased hearts. Brainomix — Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions.
Focus Sectors
BioTechHealthTechcommon.sector.deeptech
Investment Stage
SeedSeries A